Form 4 for LENZ LENZ Therapeutics, Inc.
Accepted 2022-04-13 00:00:00 ET · period of report 2022-04-11 · accession 0001209191-22-024362 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-13 | 2022-04-11 | LENZ | Gutry Phil | Chief BUSINESS Off | P - Purchase | $4.01 | +5,000 | 299.9K | +2% | +$20.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-11 | P | A | 5,000 | $4.01 | 299,941 | D | — | — | (F1) Includes 1,470 shares acquired under the Graphite Bio, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). |